Response to: Comment on "Efficay of 7-day and 14-day triple therapy regimens for the eradication of Helicobacter pylori: a comparative study in a cohort of Romanian patients".
Gastroenterology Research and Practice 2016;article ID 4760378, 2 pages
D.G.Ribaldone, GM.Saracco, R.Pellicano Two considerations on analgesic gastrointestinal tolerance.
Minerva Medica
2016;107:124
R.Pellicano, GC.Actis, GM.Saracco Response to: Reply on "Renewed Helicobacter pylori management and therapy in 2015".
Saudi Journal of Gastroenterology
2016;22:81
S.Fagoonee, R.PellicanoHelicobacter pylori and cardiovascular disease: any missing data?
European Review for Medical and Pharmacological Sciences
2015;19:4684-5
R.Pellicano Herpes zoster in patients with peptic ulcer disease: a plausible association?
International Journal of Epidemiology
2015;44:361
R.Pellicano, S.FagooneeWhy gastrointestinal tolerance would be similar for coxibs and diclofenac?
Minerva Medica
2015;106:181
S.Fagoonee, R.PellicanoHelicobacter pylori and cirrhosis: any missing data in the meta-analysis?
European Journal of Gastroenterology and Hepatology
2015;27:182-3
R.Pellicano, S.FagooneeHelicobacter pylori and the risk of myocardial infarction: any missing data in the meta-analysis?
Helicobacter
2015;20:238
R.PellicanoRe: El-Garem et al.: Seminal Helicobacter pylori treatment improves sperm motility in infertile astehenozoospermic men (Urology 2014;84:1347-50).
Urology
2015;85:1217
GP.Caviglia, S.Fagoonee, R.PellicanoEfficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy.
Panminerva
Medica
2015;57:145-6
DG.Ribaldone, S.Fagoonee, M.Astegiano, G.Saracco, R.PellicanoEfficacy of cefixime plus metronidazole therapy for Helicobacter pylori eradication: a retrospective study.
Minerva
Medica
2013;104:495-6
A.Adriani, M.Astegiano, A.Smedile, M.Rizzetto, R.PellicanoEfficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study.
Panminerva
Medica
2013;55:309-10
S.Fagoonee, M.Astegiano, A.Smedile, R.Pellicano
Is pregnancy a predisposing factor for Dieulafoy's duodenal lesion or only a coincidence?
Clinical Research in Hepatology and Gastroenterology
2013;37:e119-e120
B.Mangiavillano, C.Luigiano, S.Basile, MG.Salerno, L.Stelitano, C.Morace, P.Consolo, E.Masci, R.Pellicano,
On Helicobacter pylori seropositivity in patients with chronic obstructive pulmonary disease.
Respirology
2013;18:887
R.Pellicano,
S.Fagoonee
On Helicobacter pylori eradication and migraine: what is the accuracy of the diagnostic method?
Pain
Physician
2013;16:e121
R.Pellicano,
S.Fagoonee
Comment
on "Jeon et al. Helicobacter
pylori
infection is associated with an increased rate of diabetes".
Diabetes
Care
2013;36:e20
A.Eshraghian,
R.Pellicano
Do
not forget the gastroenterologist in the algorithm of obstructive
sleep apnea syndrome management.
Panminerva
Medica
2013;55:107
R.Pellicano,
S.Fagoonee
On
bioptic protocol after laparoscopic Nissen-Rossetti fundoplication in
patients with Barrett's esophagus.
Minerva
Chirurgica 2012;67:464
R.Pellicano
Metastases
of malignant melanoma to gastrointestinal tract: a rare event.
Giornale
Italiano di Dermatologia e Venereologia
2012;147:208-10.
M.Bassi,
C.Luigiano, R.Pellicano, F.Ferrara, A.Fornelli, D.Tassone,
N.D'Imperio
Ranitidine
bismuth citrate in the first-line of Helicobacter
pylori
treatment.
Panminerva
Medica
2011;53:137-8
F.Cisarò,
M.Astegiano, C.De Angelis, G.Saracco, M.Rizzetto, R.Pellicano
Amoxycillin
plus tetracicline as first-line Helicobacter
pylori
treatment.
Minerva
Medica
2011;102:169-70
R.Pellicano,
S.Fagoonee, M.Astegiano, A.Morgando, F.Cisarò, M.Rizzetto
Ampicillin-based
therapy for Helicobacter
pylori
eradication.
Panminerva
Medica
2011;53:261
S.Fagoonee,
R.Pellicano
Gastrointestinal
stromal tumors in Saudi Arabia.
Saudi
Medical Journal 2010;31:1076
R.Pellicano
Lipid
profile and Helicobacter pylori infection.
Journal
of Atherosclerosis and Thrombosis 2010;17:1199-200
R.Pellicano
Chest
pain in the emergency department: which role for the
gastroenterologist?
Minerva
Medica 2010;101:371-2
R.Pellicano
Prevalence
of Helicobacter pylori infection in patients with inflammatory
bowel disease: pilot study.
Revista
Española de Enfermedades Digestivas
2010;102:675-6
R.Pellicano,
F.Bresso, B.Demarchi, L.Bertolusso, N.Sapone, M.Rizzetto, M.Astegiano
Efficacy
of amoxycillin plus clavulanic acid-based triple therapy for
Helicobacter pylori eradication: a retrospective study.
Panminerva
Medica 2010;52:361-2
M.Berrutti,
M.Astegiano, A.Smedile, S.Fagoonee, M.Rizzetto, R.Pellicano
Comment
and reply on "Helicobacter
pylori
seroprevalence in patients with chronic prostatitis: a pilot study".
Scandinavian
Journal of Urology and Nephrology
2010;44:345-6
R.Pellicano,
S.Fagoonee
Efficacy
of clarithromycin plus metronidazole-based triple therapy for
Helicobacter pylori eradication: a retrospective study.
Minerva
Medica 2010;101:457-8
M.Berrutti,
S.Fagoonee, S.Strona, M.Astegiano, A.Morgando, M.Rizzetto,
R.Pellicano
Helicobacter
pylori and
insulin resistance: time to do interventional studies.
Digestive
Diseases and Sciences 2009;54:2765-6
R.Pellicano,
M.Rizzetto
Uninvestigated
dyspepsia and its related factors in an Iranian community.
Saudi
Medical Journal
2009;30:1109
R.Pellicano,
S.Fagoonee
Roxithromycin-based
therapy for Helicobacter
pylori eradication:
reply to Dr. Barbon.
Panminerva
Medica
2009;51:51-2
R.Pellicano,
S.Strona, M.Astegiano, M.Rizzetto
Efficacy
of azythromicin-based triple therapy for Helicobacter
pylori
infection: a retrospective study.
Panminerva
Medica
2008;50:259-60
R.Pellicano,
M.Astegiano, A.Smedile, G.Saracco, M.Berrutti, A.Morgando, M.Fadda,
A.Repici, S.Fagoonee, M.Rizzetto
One
question on the work on antinuclear antibody levels in patients with
Hodgkin's and non-Hodgkin's lymphoma.
Minerva
Medica
2008;99:417
M.Berrutti,
R.Pellicano,
M.Rizzetto
Helicobacter
species and type 2 diabetes mellitus: Negative results and goals of
future studies.
Saudi
Medical Journal 2008;29:1213
R.Pellicano,
M.Astegiano, M.Rizzetto
Helicobacter
pylori and atherosclerosis: can current data be useful for
clinical practice?
International
Journal of Cardiology 2008;127:288-9
R.Pellicano,
S.Fagoonee
Gastroesophageal
reflux disease is frequently present in patients with laryngeal and
voice disorders.
Saudi
Medical Journal 2008;29:315
R.Pellicano,
S.Fagoonee
On
acute respiratory tract infections and acute myocardial
infarction.New data confirm previous findings.
International
Angiology 2007;26:391-2
E.Oliaro,
S.Fagoonee, R.Pellicano
On
infections and ischemic heart diseases.
International
Angiology 2007;26:390-1
R.Pellicano,
S.Fagoonee, M.Rizzetto
Helicobacter
pylori and coronary artery disease: which is the better
target population?
Digestive
Diseases and Sciences 2007;52:3041-2
R.Pellicano,
M.Rizzetto
Helicobacter
pylori and ischemic heart disease. Which potential
pathogenic mechanisms?
Saudi
Medical Journal 2006;27:427
R.Pellicano,
M.Astegiano, M.Rizzetto
Helicobacter
pylori infection and coronary heart disease: a continue
debated question.
Panminerva
Medica 2001;43:139-40
R.Pellicano,
M.Astegiano, S.Fagoonee, M.Rizzetto
Helicobacter
pylori e malattie
cardiovascolari. [Helicobacter
pylori and cardiovascular diseases]
Interni
di Vita Medica 1999;2:9-11
R.Pellicano,
A.Ponzetto
Eradication
of Helicobacter pylori
infection and metronidazole resistance: different results in
different countries.
Saudi
Medical Journal 1998;19:215-6
R.Pellicano,
M.Rizzetto, A.Ponzetto, SM.Al-Amry, B.Al-Knawy
Infezione
da Helicobacter pylori e patologie vascolari:
mito o realtà?
[Helicobacter
pylori and vascular diseases: myth or reality?]
Cardiologia
Ambulatoriale
1998;2:20
A.Ponzetto,
R.Pellicano
Cigarette
smokers and non smokers suffer of duodenal ulcer relapse rarely after
cure of Helicobacter
pylori
infection.
European
Journal of Internal Medicine
1997;8(2):131
A.Ponzetto,
R.Pellicano,
F.Palmas, B.Demarchi, M.Rizzetto
On elevated alanine aminotransferase in type 1 diabetes mellitus.
Serum cytokeratin-18 levels for liver fibrosis prediction.
Minerva Gastroenterologica Dietologica 2016;62:223
R.Pellicano, GM.Saracco
Serum cytokeratin-18 levels for liver fibrosis prediction.
Hepatitis
Monthly
2015;15:e30853
Vitamin D and NAFLD: the need for interventional trials.
Minerva
Medica 2014;105:261
S.Fagoonee,
R.Pellicano
A comment on resistin, NASH and fibrosis.
Minerva
Medica 2013;102:235-6
S.Fagoonee,
R.Pellicano
The
evolving incidence of hepatitis C virus infection in Italy.
Hepatitis
Monthly
2012;12:124-5
R.Pellicano,
S.Fagoonee
Nonalcoholic
fatty liver disease in south India.
Journal
Postgraduate Medicine 2011;57:257-8
R.Pellicano,
S.Fagoonee
Insulin
resistance in China.
Saudi
Medical Journal 2011;32:648
R.Pellicano,
S.Fagoonee
Practical
out-patient management of autoimmune hepatitis.
Panminerva
Medica 2010;52:265
E.Vanni,
G.C.Actis, A.Ciancio, R.Pellicano, M.L.Abate, G.A.Touscoz,
A.Smedile, M.Rizzetto
HCV
and TTV co-infection in Turin, Italy.
Digestive
Diseases and Sciences
2009;54:1154-5
R.Pellicano,
A.Olivero, ML.Abate, A.Smedile, M.Rizzetto
Prevalence
of hepatitis C virus/hepatitis G virus co-infection in Turin: updated
data ten years later.
Panminerva
Medica 2008;50:82-3
R.Pellicano,
A.Olivero, M.L.Abate, A.Smedile, M.Rizzetto
Clinical
features of acute hepatitis C of nosocomial origin in Bulgaria.
Panminerva
Medica
2007;49:98-100
L.Pekova,
I.Mladenova, R.Pellicano
Erythropoietin
in liver cirrhosis: Two questions without answers.
World
Journal of Gastroenterology 2005;11:3649
CM.Bruno,
C.Sciacca, D.Cilio, G.Bertino, R.Pellicano
The
exacerbation of psoriasis during treatment with alfa interferon.
Recenti
Progressi in Medicina 1997;9:423
R.Pellicano,
P.Puiatti, P.Palmas, M.Rizzetto, A.Ponzetto
On "Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas".
On inverse association between Helicobacter pylori gastritis and microscopic colitis: The European data.
Reply to: Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders.
Ulcerative proctitis in out-patient practice: an unexpected clinical challenge.
Intrahepatic cholestasis in Bruton's agammaglobulinemia receiving mesalamine for co-morbid Crohn's disease.
Pancolitis
during etanercept treatment of rheumatoid arthritis relapsing on the
administration of further two TNF-alpha inhibitors.
Panminerva Medica 2016;58:102
GP.Caviglia, R.Pellicano
On inverse association between Helicobacter pylori gastritis and microscopic colitis: The European data.
Inflammatory Bowel Disease 2016;22:E11-2
DG.Ribaldone, D.Simondi, M.Astegiano, R.Pellicano
Co-morbid immunopathological affections in outpatients with inflammatory bowel disease: a prospective study.
Co-morbid immunopathological affections in outpatients with inflammatory bowel disease: a prospective study.
Minerva Gastroenterologica Dietologica 2016;62:270-1
GC.Actis, R.Pellicano
Reply to: Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders.
Scandinavian Journal of Gastroenterology 2015;50:623-4
GP.Caviglia, R.Pellicano, M. Astegiano A case of appendectomy as main therapeutic intervention for complex co-morbid ulcerative proctitis.
International
Journal of Colorectal Diseases 2015;30:1747-8
GC.Actis, F.Rosina, R.Pellicano,
Ulcerative proctitis in out-patient practice: an unexpected clinical challenge.
Minerva Gastroenterologica Dietologica 2014;60:201
GC.Actis, R.Pellicano, F.Rosina
Intrahepatic cholestasis in Bruton's agammaglobulinemia receiving mesalamine for co-morbid Crohn's disease.
Journal of Pharmacology and Pharmacotherapeutics 2014;5:151-2
GC.Actis, R.Pellicano, F.Rosina
International
Journal of Colorectal Diseases 2012;27:547-8
GC.Actis,
M.Lagget, R.Pellicano, F.Rosina
High
rate of microscopic colitis in patients with Marsh I-II duodenal
damage.
Scandinavian
Journal of Gastroenterology 2009;4:1-2
M.Astegiano,
R.Pellicano, G.Verme, M.Rizzetto
How
important is mesalamine in the maintenance of steroid-refractory
colitis?
Inflammatory
Bowel Disease 2008;14:1026
GC.Actis,
A.Marzano, R.Pellicano, M.Rizzetto
Rescue
with Infliximab and surgical outcomes for refractory ulcerative
colitis.
Journal
American College Surgeons 2007;205:e3-e4
GC.Actis,
R.Pellicano, M.Pinna-Pintor,
M.Rizzetto
Screening
for coeliac disease in women with recurrent spontaneous abortion
sine causa.
Panminerva
Medica 2000;42:299-300
R.Pellicano,
M.Astegiano, S.Fagoonee, M.Rizzetto
Methodology and internal
medicine
Personal
point of view on the 2008 life expectancy at birth: the positive
results of Italian medicine.
Minerva
Medica
2009;100:1
R.Pellicano
Circulating
erythropoietin in diabetes mellitus.
Diabetic
Medicine 2005;22:1780-1
CM.Bruno,
D.Cilio, C.Sciacca, R.Pellicano
